| P50 | author | Peter Ridefelt | Q59624321 |
| P2093 | author name string | Michael Wagner | |
| | Marie Carlson | |
| | Per Sangfelt | |
| | Christer G B Peterson | |
| P2860 | cites work | Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein | Q73325657 |
| | Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents | Q74558129 |
| | Faecal calprotectin: a marker of inflammation throughout the intestinal tract | Q74598383 |
| | VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS | Q76593193 |
| | Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion | Q78001470 |
| | Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy | Q79835010 |
| | Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease | Q79895433 |
| | Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease | Q79925815 |
| | Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease | Q80928529 |
| | Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis | Q81527827 |
| | A simple method for assessing intestinal inflammation in Crohn's disease | Q24669833 |
| | Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease | Q24685692 |
| | Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children | Q28196268 |
| | A simple index of Crohn's-disease activity | Q28259898 |
| | Role of faecal calprotectin as non-invasive marker of intestinal inflammation. | Q34270506 |
| | Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities | Q34479597 |
| | Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis | Q35594493 |
| | Review article: biological activity markers in inflammatory bowel disease | Q36705334 |
| | Functional and clinical aspects of the myelomonocyte protein calprotectin | Q37228215 |
| | Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease | Q41609900 |
| | Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease | Q41746265 |
| | Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease | Q41808481 |
| | Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis | Q43584414 |
| | Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States | Q44012018 |
| | A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease | Q44074816 |
| | Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis | Q44770139 |
| | Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. | Q46008397 |
| | Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. | Q50754207 |
| | Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis | Q52477532 |
| | Biopsy studies in ulcerative colitis. | Q55502456 |
| | Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease | Q57675111 |
| | Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study | Q67563010 |
| | An indicator of Crohn's disease activity. A need unfulfilled | Q69572045 |
| | Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion | Q70029635 |
| | Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins | Q71085690 |
| | A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis | Q71579835 |
| | Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease | Q73074079 |
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | feces | Q496 |
| | inflammation | Q101991 |
| | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 5584-9; discussion 5588 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease | |
| P478 | volume | 14 | |